Cardinal Health vs. McKesson: Which Pharmaceutical Giant Reigns Supreme?

Tuesday, Mar 24, 2026 11:32 am ET1min read
CAH--
MCK--

Cardinal Health and McKesson are two pharmaceutical distributors with different strategic positioning. Cardinal Health is transitioning from restructuring to growth, leveraging specialty expansion and operational efficiency, while McKesson operates from a position of strength, refining its established platform. Cardinal Health has shown renewed momentum, with 19% revenue growth and 38% operating earnings rise, positioning it as an increasingly compelling investment opportunity. McKesson maintains steady execution with 11% revenue growth and 16% EPS rise, but its momentum appears more incremental than transformational.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet